Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced the successful completion of the tender offer for all of the
outstanding shares of common stock of Idenix Pharmaceuticals, Inc.
(NASDAQ:IDIX) at a purchase price of $24.50 per share.
Language:
English
Contact:
MerckMedia:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more